Documente Academic
Documente Profesional
Documente Cultură
VerDate Aug<31>2005 13:56 Nov 15, 2005 Jkt 208001 PO 00000 Frm 00072 Fmt 4703 Sfmt 4703 E:\FR\FM\16NON1.SGM 16NON1
69580 Federal Register / Vol. 70, No. 220 / Wednesday, November 16, 2005 / Notices
provisions set forth in sections provisions set forth in sections would constitute a clearly unwarranted
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., invasion of personal privacy.
as amended. The grant applications and as amended. The grant applications and Name of Committee: National Institute of
the discussions could disclose the discussions could disclose Diabetes and Digestive and Kidney Diseases
confidential trade secrets or commercial confidential trade secrets or commercial Special Emphasis Panel. Review of R03 Grant
property such as patentable material, property such as patentable material, Application.
and personal information concerning and personal information concerning Date: November 28, 2005.
individuals associated with the grant individuals associated with the grant Time: 2 p.m. to 3 p.m.
applications, the disclosure of which applications, the disclosure of which Agenda: To review and evaluate grant
would constitute a clearly unwarranted would constitute a clearly unwarranted applications.
Place: National Institutes of Health, Two
invasion of personal privacy. invasion of personal privacy. Democracy Plaza, 6707 Democracy
Name of Committee: National Institute of Name of Committee: National Institute on Boulevard, Bethesda, MD 20892. (Telephone
Biomedical Imaging and Bioengineering Drug Abuse Special Emphasis Panel, Review Conference Call).
Special Emphasis Panel, NIH–NIBIB P01–J3 of Time Sensitive Applications. Contact Person: Neal A. Musto, PhD,
Review Meeting. Date: November 14, 2005. Scientific Review Administrator, Review
Date: November 18, 2005. Time: 2 p.m. to 6 p.m. Branch, DEA, NIDDK, National Institutes of
Time: 8 a.m. to 1:30 p.m. Agenda: To review and evaluate grant Health, Room 751, 6707 Democracy
Agenda: To review and evaluate grant applications. Boulevard, Bethesda, MD 20892–5452. (301)
applications. Place: National Institutes of Health, 6101 594–7798. muston@extra.niddk.nih.gov.
Place: Bethesda Park Hotel, 840 Wisconsin Executive Boulevard, Rockville, MD 20852, This notice is being published less than 15
Avenue, Bethesda, MD 20814. (Telephone Conference Call). days prior to the meeting due to the timing
Contact Person: Prabha L. Atreya, PhD, Contact Person: Meenaxi Hiremath, PhD, limitations imposed by the review and
Scientific Review Administrator, Office of Health Scientist Administrator, Office of funding cycle.
Scientific Review, National Institute of Extramural Affairs, National Institute on
(Catalogue of Federal Domestic Assistance
Biomedical Imaging, and Bioengineering, Drug Abuse, National Institutes of Health,
Program Nos. 93.847, Diabetes,
Bethesda, MD 20892, (301) 496–8633, DHHS, 6101 Executive Blvd., Suite 220, MSC
Endocrinology and Metabolic Research;
atreyapr@mail.nih.gov. 8401, Bethesda, MD 20892, 301–402–7964,
93.848, Digestive Diseases and Nutrition
This notice is being published less than 15 mh392g@nih.gov.
Research; 93.849, Kidney Diseases, Urology
days prior to the meeting due to the timing This notice is being published less than 15
and Hematology Research, National Institutes
limitations imposed by the review and days prior to the meeting due to the timing
of Health, HHS)
funding cycle. limitations imposed by the review and
funding cycle. Dated: November 4, 2005.
Name of Committee: National Institute of
Biomedical Imaging and Bioengineering (Catalogue of Federal Domestic Assistance Anna Snouffer,
Special Emphasis Panel, NIBIB–R13 Program Nos. 93.306, Comparative Medicine; Acting Director, Office of Federal Advisory
Conference Review Meeting. 93.333, Clinical Research; 93.306, 93.333, Committee Policy.
Date: December 7, 2005. 93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National [FR Doc. 05–22687 Filed 11–15–05; 8:45 am]
Time: 10 a.m. to 12:30 p.m. BILLING CODE 4140–01–M
Agenda: To review and evaluate grant Institutes of Health, HHS)
applications. Dated: November 7, 2005.
Place: II Democracy Plaza, Dem. II, 6707 Anna Snouffer,
Democracy Blvd. 223, Bethesda, MD 20817, DEPARTMENT OF HEALTH AND
Acting Director, Office of Federal Advisory HUMAN SERVICES
(Telephone Conference Call).
Committee Policy.
Contact Person: Bonnie Dunn, PhD,
Scientific Review Administrator, Office of [FR Doc. 05–22686 Filed 11–15–05; 8:45 am] National Institutes of Health
Scientific Review, National Institute of BILLING CODE 4140–01–M
Biomedical Imaging and Bioengineering, National Institute of Neurological
6707 Democracy Blvd., Suite 920, Bethesda, Disorders and Stroke; Notice of Closed
MD 20892, (301) 496–8633, DEPARTMENT OF HEALTH AND Meetings
dunnbo@mail.nih.gov. HUMAN SERVICES Pursuant to section 10(d) of the
Dated: November 7, 2005. Federal Advisory Committee Act, as
Anna Snouffer,
National Institutes of Health
amended (5 U.S.C. Appendix 2), notice
Acting Director, Office of Federal Advisory National Institute of Diabetes and is hereby given of the following
Committee Policy. Digestive and Kidney Diseases; Notice meetings.
[FR Doc. 05–22683 Filed 11–15–05; 8:45 am] of Closed Meeting The meetings will be closed to the
BILLING CODE 4140–01–M public in accordance with the
Pursuant to section 10(d) of the provisions set forth in sections
Federal Advisory Committee Act, as 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
DEPARTMENT OF HEALTH AND amended (5 U.S.C. Appendix 2), notice as amended. The grant applications and
HUMAN SERVICES is hereby given of the following the discussions could disclose
meeting. confidential trade secrets or commercial
National Institutes of Health The meeting will be closed to the property such as patentable material,
public in accordance with the and personal information concerning
National Institute on Drug Abuse; provisions set forth in sections individuals associated with the grant
Notice of Closed Meeting 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., applications, the disclosure of which
Pursuant to section 10(d) of the as amended. The grant applications and would constitute a clearly unwarranted
Federal Advisory Committee Act, as the discussions could disclose invasion of personal privacy.
amended (5 U.S.C. Appendix 2), notice confidential trade secrets or commercial Name of Committee: National Institute of
is hereby given of the following property such as patentable material, Neurological Disorders and Stroke Special
meeting. and personal information concerning Emphasis Panel. Fellowship Review.
The meeting will be closed to the individuals associated with the grant Date: November 29, 2005.
public in accordance with the applications, the disclosure of which Time: 8 a.m. to 5 p.m.
VerDate Aug<31>2005 13:56 Nov 15, 2005 Jkt 208001 PO 00000 Frm 00073 Fmt 4703 Sfmt 4703 E:\FR\FM\16NON1.SGM 16NON1